What investment strategy does Amadeus Capital Partners focus on?

Amadeus Capital Partners focuses on VC, Growth strategies in the private equity space.

How many portfolio companies does Amadeus Capital Partners have?

Amadeus Capital Partners has 9 active portfolio companies and 3 funds tracked on GP Intel.

Where is Amadeus Capital Partners headquartered?

Amadeus Capital Partners is headquartered in London, United Kingdom.

When was Amadeus Capital Partners founded?

Amadeus Capital Partners was founded in 1997.

What sectors does Amadeus Capital Partners invest in?

Amadeus Capital Partners invests across TMT, Software, Healthcare, Financials.

Home/GPs/Amadeus Capital Partners

Amadeus Capital Partners

London, United Kingdom·Founded 1997·

Venture Capital Growth Equity

·amadeuscapital.com

Amadeus Capital Partners Limited is a London-based venture capital firm founded in 1997 by Hermann Hauser and Anne Glover to back deep-technology companies. Operating from London and Cambridge, the firm invests from seed to growth stage…Read full bio

AUM

–

Funds

About Amadeus Capital Partners

Amadeus Capital Partners is a UK deep technology venture capital firm with more than $1.3 billion of cumulative capital raised, headquartered in London. The firm was founded in 1997 by Anne Glover and Hermann Hauser (co-founder of ARM), and has built a 25 plus year track record in European deep tech investing with 17 portfolio IPOs and more than 200 companies backed. Amadeus remains a founder-led partner-owned independent firm.

Investment thesis

Amadeus deploys capital across approximately five main Amadeus funds (I through V, including £110 million Amadeus V Technology Fund) plus the €80 million Amadeus APEX Technology Fund and an Early-Stage EIS Fund, supporting deep tech ventures from seed through growth stages. Sector focus spans artificial intelligence, quantum computing, cybersecurity, digital health, enterprise software and sustainability and energy, with particular emphasis on UK and European university spinouts and frontier technology platforms. Geographic deployment spans the UK and broader Europe as primary markets with Latin America accessed via the APEX Technology Fund partnership.

Recent activity

Recent realised exits include medical technology (organ transplantation, 2025) and fintech (fraud prevention, 2025). Recent investments include Riverlane (quantum computing, 2024 round), Vertus Energy (renewables, 2024), Safe Intelligence (AI validation, 2025), Sitehop (post-quantum cryptography, 2024), Refute (2025) and Nu Quantum (2025). The platform continues active deployment across its deep tech thesis with selective follow-on investment across the existing portfolio. Detailed buyer names and multiple data available on Pro at €49/month.